Your browser doesn't support javascript.
loading
Quantitative biophysical analysis defines key components modulating recruitment of the GTPase KRAS to the plasma membrane.
Lakshman, Bindu; Messing, Simon; Schmid, Eva M; Clogston, Jeffrey D; Gillette, William K; Esposito, Dominic; Kessing, Bailey; Fletcher, Daniel A; Nissley, Dwight V; McCormick, Frank; Stephen, Andrew G; Jean-Francois, Frantz L.
Afiliación
  • Lakshman B; From the NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21702.
  • Messing S; From the NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21702.
  • Schmid EM; Department of Bioengineering, University of California Berkeley, Berkeley, California 94720.
  • Clogston JD; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, 21702.
  • Gillette WK; From the NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21702.
  • Esposito D; From the NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21702.
  • Kessing B; From the NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21702.
  • Fletcher DA; Department of Bioengineering, University of California Berkeley, Berkeley, California 94720.
  • Nissley DV; Division of Biological Systems and Engineering, Lawrence Berkeley National Laboratory, Berkeley, California 94720.
  • McCormick F; Chan Zuckerberg Biohub, San Francisco, California 94158.
  • Stephen AG; From the NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21702.
  • Jean-Francois FL; From the NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland 21702.
J Biol Chem ; 294(6): 2193-2207, 2019 02 08.
Article en En | MEDLINE | ID: mdl-30559287

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Membrana Celular / Proteínas Proto-Oncogénicas p21(ras) Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Biol Chem Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Membrana Celular / Proteínas Proto-Oncogénicas p21(ras) Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Biol Chem Año: 2019 Tipo del documento: Article